2015 Antineoplastics
Overview
|
Cancer treatment
|
General Concepts
|
Prevent DNA synthesis
|
Disrupt DNA
|
Antimitotics
|
Immune System Modulators
|
Target Proteins
|
Angiogenesis Inhibitors
|
Differentiating Agents
|
Interfere with Hormone Function
|
Treatment Strategies
|
Breast cancer treatment
Protein Function Inhibitors
/
Proteosome inhibitor
/ Therapeutic uses
Proteosome inhibitor:
BORTEZOMIB
Therapeutic uses
multiple myeloma
search
Drug cards
Approaches
Target Tyrosine Kinases
Bcr-Abl
Mechanism
Pharmacokinetics
Resistance
Therapeutic uses
Toxicities
EGFR
Mechanism
Therapeutic uses
Toxicities
Comparison
Block HER2
Target altered processes
L-asparaginase
Proteosome inhibitors
Mechanism
Therapeutic uses
Toxicity
HDAC inhibitors
Mechanism
Toxicity
Email: Dr. Janet Fitzakerley
| ©2015 University of Minnesota Medical School Duluth | Last modified: 11-apr-15 9:39 AM